SINOVAC, a Chinese leading biopharmaceutical company and one of the largest producers of vaccines against Covid-19 in the world, on the installation and development of its operation in Chile, which is the first one in the region. The representation included, among others, advice on the incorporation of a Chilean subsidiary, the purchase of a real estate for a fill & finish vaccine facility in Santiago, Chile, of more than 21,000 mt², the entrance of the initial capital funds to Chile, regulatory issues and on labor and immigration matters related to the Chilean and foreign employees who will render services to Sinovac Chile.